Amgen Inc. develops, manufactures, and delivers human therapeutics worldwide. The companys principal products treat various conditions including psoriasis, arthritis, osteoporosis, and cancer. Additional products include Repatha for cardiovascular risk reduction and Neulasta for neutropenia prevention. Amgen serves healthcare providers, pharmaceutical wholesale distributors, and direct-to-consumer channels. The company has collaborations with AstraZeneca, Novartis, UCB, Kyowa Kirin, and BeiGene. Founded in 1980, Amgen is headquartered in Thousand Oaks, California.
| Indicator | Value |
|---|---|
| PER | 39.9 |
| EV/EBITDA | 15.8 |
| Price/Free Cash Flow' | 15.7 |
| ROIC | 17.4% |
| Net Debt/EBITDA | 3.6 |